You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Moodys
Boehringer Ingelheim
Medtronic
AstraZeneca

Last Updated: December 2, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PTI-801

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for PTI-801?

PTI-801 is an investigational drug.

There have been 22 clinical trials for PTI-801. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Fibrosis, Cystic Fibrosis, and Alzheimer Disease. The leading clinical trial sponsors are Proteostasis Therapeutics, Inc., Pain Therapeutics, and Cassava Sciences, Inc.

There is one US patent protecting this investigational drug and fourteen international patents.

Recent Clinical Trials for PTI-801
TitleSponsorPhase
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular EdemaHoffmann-La RochePhase 3
PTI-125, 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsNational Institute on Aging (NIA)Phase 2
PTI-125, 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsCassava Sciences, Inc.Phase 2

See all PTI-801 clinical trials

Clinical Trial Summary for PTI-801

Top disease conditions for PTI-801
Top clinical trial sponsors for PTI-801

See all PTI-801 clinical trials

International Patents for PTI-801

Drugname Country Document Number Estimated Expiration Related US Patent
PTI-801 Argentina AR106279 2035-10-06   Start Trial
PTI-801 Australia AU2016336437 2035-10-06   Start Trial
PTI-801 Brazil BR112018007021 2035-10-06   Start Trial
PTI-801 Canada CA3000483 2035-10-06   Start Trial
PTI-801 China CN108430994 2035-10-06   Start Trial
PTI-801 European Patent Office EP3359536 2035-10-06   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Moodys
Boehringer Ingelheim
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.